Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Wilfond

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Hastings Center Report|May 1, 1995
Screening policy for cystic fibrosis. The role of evidenceB S Wilfond
The Journal of Clinical Ethics|January 1, 1995
Genetic counseling, non-directiveness, and clients' values: is what clients say, what they mean?B S Wilfond, D Baker
The Milbank Quarterly|January 1, 1992
The introduction of cystic fibrosis carrier screening into clinical practice: policy considerationsB S Wilfond, N Fost
JAMA|December 22, 1993
National policy development for the clinical application of genetic diagnostic technologies. Lessons from cystic fibrosisB S Wilfond, K Nolan
JAMA|May 23, 1990
The cystic fibrosis gene: medical and social implications for heterozygote detectionB S Wilfond, N Fost
American Journal of Human Genetics|October 1, 1992
Twice-told tales: stories about genetic disordersA Lippman, B S Wilfond
The New England Journal of Medicine|October 13, 1994
Generic consent for genetic screeningL G Biesecker, B S Wilfond
Human Gene Therapy|May 16, 2000
Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boardsI M Burger, B S Wilfond
American Journal of Human Genetics|October 3, 1998
Mixed messages: presentation of information in cystic fibrosis-screening pamphletsG L Loeben, T M Marteau, B S Wilfond
Clinical Pediatrics|January 1, 1994
Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screeningB S Wilfond, P M Farrell, A Laxova, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Hastings Center Report|May 1, 1995
Screening policy for cystic fibrosis. The role of evidenceB S Wilfond
The Journal of Clinical Ethics|January 1, 1995
Genetic counseling, non-directiveness, and clients' values: is what clients say, what they mean?B S Wilfond, D Baker
The Milbank Quarterly|January 1, 1992
The introduction of cystic fibrosis carrier screening into clinical practice: policy considerationsB S Wilfond, N Fost
JAMA|December 22, 1993
National policy development for the clinical application of genetic diagnostic technologies. Lessons from cystic fibrosisB S Wilfond, K Nolan
JAMA|May 23, 1990
The cystic fibrosis gene: medical and social implications for heterozygote detectionB S Wilfond, N Fost
American Journal of Human Genetics|October 1, 1992
Twice-told tales: stories about genetic disordersA Lippman, B S Wilfond
The New England Journal of Medicine|October 13, 1994
Generic consent for genetic screeningL G Biesecker, B S Wilfond
Human Gene Therapy|May 16, 2000
Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boardsI M Burger, B S Wilfond
American Journal of Human Genetics|October 3, 1998
Mixed messages: presentation of information in cystic fibrosis-screening pamphletsG L Loeben, T M Marteau, B S Wilfond
Clinical Pediatrics|January 1, 1994
Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screeningB S Wilfond, P M Farrell, A Laxova, et al.
Pageof 3